AstraZeneca and the University of Cambridge Judge Business School announced an agreement to deliver a new “Accelerate Cambridge Life Sciences” programme which will identify, train and mentor start-up ventures in the life sciences. Jelena Aleksic, founder and CEO of Accelerate Cambridge startup GeneAdviser said this partnership “is both timely and highly promising in terms of further developing the life science cluster in the area.”
Read the full article [cambridge-news.co.uk]
Comments